Imipenem-relebactam: Difference between revisions
From IDWiki
(Created page with "== Background == === Mechanism of Action === * Relebactam improves activity against beta-lactamases including class A and C === Spectrum of Activity === * Active against E...") |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
== |
==Background== |
||
=== |
===Mechanism of Action=== |
||
* |
*Relebactam improves activity against beta-lactamases including class A and C |
||
*Also includes cilastatin, as per usual with imipenem |
|||
=== |
===Spectrum of Activity=== |
||
* |
*Active against Enterobacterales including ESBL, AmpC, and KPC, Bacteroides, MDR Pseudomonas |
||
* |
*No activity against many Gram-positives or afermentative Gram-negatives |
||
[[Category:Carbapenems]] |
|||
[[Category:β-lactamase inhibitors]] |
|||
Latest revision as of 14:02, 26 August 2020
Background
Mechanism of Action
- Relebactam improves activity against beta-lactamases including class A and C
- Also includes cilastatin, as per usual with imipenem
Spectrum of Activity
- Active against Enterobacterales including ESBL, AmpC, and KPC, Bacteroides, MDR Pseudomonas
- No activity against many Gram-positives or afermentative Gram-negatives
